Can nonproliferative breast disease and proliferative breast disease without atypia be distinguished by fine-needle aspiration cytology?

Cancer

Volumn 81, Issue 1, 1997, Pages 22-28

  Frost, Andra R ^a,c   Aksu, Aziz ^a   Kurstin, Ronald ^b   Sidawy, Mary K ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^c GEORGE WASHINGTON UNIVERSITY HOSPITAL   (United States)

Author keywords

Benign; Breast; Fibrocystic change; Fine needle aspiration cytology; Nonproliferative breast disease; Proliferative breast disease

Indexed keywords

ADULT; AGED; ARTICLE; ASPIRATION CYTOLOGY; BREAST CARCINOMA; BREAST DISEASE; CELL NUCLEUS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MYOEPITHELIUM CELL; PRIORITY JOURNAL;

BIOPSY, NEEDLE; BREAST DISEASES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE OF TESTS;

EID: 0031585833     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970225)81:1<22::AID-CNCR6>3.0.CO;2-I     Document Type: Article

References (23)

1. Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast: a long-term follow-up study. Cancer 1985;55:2698-708.
2. Page DL. Cancer risk assessment in benign breast biopsies. Hum Pathol 1986;17:871-4.
3. Page DL, Anderson TJ, Rogers LW. Epithelial hyperplasia. In: Diagnostic histopathology of the breast. New York: Churchill Livingstone, 1987:120-45.
4. Page DL, Anderson TJ, Rogers LW. Carcinoma in situ (CIS). In: Diagnostic histopathology of the breast. New York: Churchill Livingstone, 1987:157-92.
5. Rosai J. Borderline epithelial lesions of the breast. Am J Surg Pathol 1991;15:209-21.
6. Schnitt SJ, Connolly JL, Tavassoli FA, Fechner RE, Kempson RL, Gelman R, et al. Interobserver reproducibility in the diagnosis of proliferative breast lesions using standardized criteria. Am J Surg Pathol 1992;16:1133-43.
7. Abendroth CS, Wang HH, Ducatman BS. Comparative features of carcinoma in situ and atypical ductal hyperplasia of the breast on fine needle aspiration biopsy specimens. Am J Clin Pathol 1991;96:654-9.
8. Dawson AE, Mulford DK, Sheils LA. The cytopathology of proliferative breast disease: comparison with features of ductal carcinoma in situ. Am J Clin Pathol 1995;103:438-42.
9. Dziura BR, Bonfiglio TA. Needle cytology of the breast: a quantitative and qualitative study of the cells of benign and malignant ductal neoplasia. Acta Cytol 1979;23:332-40.
10. Masood S, Frykberg ER, McLellan GL, Scalapino MC, Mitchum DG, Bullard JB. Prospective evaluation of radiologically directed fine-needle aspiration biopsy of nonpalpable breast lesions. Cancer 1990;66:1480-7.
11. Masood S, Frykberg ER, McLellan GL, Dee S, Bullard JB. Cytologic differentiation between proliferative and nonproliferative breast disease in mammographically guided fine needle aspirates. Diagn Cytopathol 1991;7:581-90.
12. Sneige N, Staerkel GA. Fine needle aspiration cytology of ductal hyperplasia with and without atypia and ductal carcinoma in situ. Hum Pathol 1994;25:485-92.
13. Thomas PA, Cangiarella J, Raab SS, Waisman J. Fine needle aspiration biopsy of proliferative breast disease. Mod Pathol 1995;8:130-6.
14. Maygarden S, McCall JB, Frable WJ. Fine needle aspiration of breast lesions in women aged 30 and under. Acta Cytol 1991;35:678-94.
15. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985; 312:146-51.
16. Marshall CJ, Schumann GB, Ward JH, Riding JM, Cannon-Albright L, Skolnick M. Cytologic identification of clinically occult proliferative breast disease in women with a family history of breast cancer. Am J Clin Pathol 1991;95:157-65.
17. Skolnick MH, Cannon-Albright LA, Goldgar DE, Ward JH, Marshall CJ, Schumann GB, et al. Inheritance of proliferative breast disease in breast cancer kindreds. Science 1990; 250:1715-20.
18. Page DL, Dupont WD. Proliferative breast disease: diagnosis and implications [technical comments]. Science 1991; 253:915-6.
19. Sidawy MK, Stoler MH, Frable WJ, Frost AR, Masood S, Miller TR, et al. Interobserver variability in the classification of proliferative breast lesions by fine needle aspiration: results of the Papanicolaou Society of Cytopathology Study. Acta Cytol 1995;39:973-4.
20. Longacre TA, Bartow SA. A correlative morphologic study of human breast and endometrium in the menstrual cycle. Am J Surg Pathol 1986;10:382-93.
21. Stanley MW, Henry-Stanley MJ, Zera R. Atypia in breast fine-needle aspiration smears correlates poorly with the presence of a prognostically significant proliferative lesion of ductal epithelium. Hum Pathol 1993;24:630-5.
22. Silverman J, Masood S, Ducatman BS, Wang H, Sneige N. Can FNA biopsy separate atypical hyperplasia, carcinoma in situ, and invasive carcinoma of the breast? Cytomorphologic criteria and limitations in diagnosis. Diagn Cytopathol 1993;9:713-28.
23. King EB, Chew KL, Duarte L, Horn J, Mayall BH, Miller TR, et al. Image cytometric classification of premalignant breast disease in fine needle aspirates. Cancer 1988;62:114-24.